Data released recently by the Centers for Disease Control and Prevention showed over 9,000 reports of deaths for all age groups in the US from the COVID vaccines. The latest numbers show an increase of more than 2,000 compared with the previous week. The data comes directly from reports submitted to the CDC’s Vaccine Adverse Event Reporting System (VAERS).
VAERS, the CDC’s primary mechanism in the U.S. for reporting adverse vaccine reactions, historically only reports 1% of the total actual adverse events according to a Harvard study. Reports to the system come from medical professionals regarding patients, and most are failed to be reported for various reasons.
Some experts say that if VAERS only reports approximately 1% of the total adverse events from vaccines, the high number of adverse reactions already reported to VAERS by healthcare professionals could possibly be much higher.
The newest data show that between Dec. 14, 2020, and May 28, a total of 438,441 total adverse events were reported to VAERS, including 9,048 deaths.
The Centers for Disease Control (CDC) held an emergency meeting on June 18 to discuss reports of heart inflammation in youths after doses of COVID-19 vaccine.
The official reporting from VAERS shows more than 1,200 cases of myocarditis or pericarditis in people under 30, but experts say the same flaw Harvard found with the VAERS data overall exists in those numbers as well.
Following the meeting, a CDC safety group concluded that there’s an association between a heart inflammatory condition in adolescents and young adults after they’ve received their second Covid-19 vaccine shot.
Coronavirus vaccines may be widely available by the fall for U.S. children as young as 6 months, drugmakers say. Some schools may move to mandate the vaccines for children to be able to return to classes without masks.
According to experts, children are half as likely to get COVID-19, and those that do mostly experience mild, almost unnoticeable symptoms, or no symptoms or at all.
The latest data shows the vaccines have very low efficacy against the new Delta variant of coronavirus and an even lower efficacy against the Lambda variant.
Around 90% of the people in the UK and Israel are contracting the Delta variant of the virus. Around 50% of those people have been fully vaccinated with the new MRNA technology.
Pfizer announced Thursday that it will seek FDA authorization for a booster shot of its COVID-19 vaccine as the company acknowledges its two-dose vaccine has shown waning effectiveness against variants.
According to doctors, the Delta variant’s symptoms are much milder. Dr. David Priest, an infectious disease specialist with Novant Health, said while the loss of taste and smell was the most telltale sign of the coronavirus throughout the pandemic, many getting sick with delta present with more mild symptoms, like a runny nose or sore throat.
The symptoms closely resemble the common cold or hay fever.
According to the first-quarter results published by Pfizer this week, its coronavirus jab has reaped revenues of $3.5bn for the biopharma giant in the first three months of 2021.
The financial results also revealed that Pfizer has vastly exceeded its Covid-19 vaccine sales forecast of $15bn, and now expects the jab to bring in $26bn of revenue in 2021 – an increase of 73% on previously anticipated figures.
